Staff Members - Benha University
Role of BoneMarrowDerived MesenchymalStemCellsandthe Protective EffectofSilymarinin Cisplatin-Induced AcuteRenal Failure in RatsRole ofBoneMarrowDerived MesenchymalStemCellsandthe Protective EffectofSilymarinin Cisplatin-Induced AcuteRenal Failure inRats
Am J Med Sci 2018;355(1):76–83 • 2018
Publication Information
Authors
Mohamed El-TantawyIbrahim, EmanElBana,and Hanan I.El-Kerdasy
Keywords
Key Indexing Terms: Cisplatin; Silymarin; Mesenchymal stem cells; Acute renal failure. [Am J Med Sci 2018;355(1):76–83.]
Journal
Am J Med Sci 2018;355(1):76–83
Publisher
Not Available
Volume
355
Issue
(1):
Pages
76–83
publication.type
International
Paper Link
Open Link
Supplementary Materials
Not Available
Abstract
Background: Cisplatin is a highly effective antitumor agent whose clinical application is limited by its nephrotoxicity, which is
associated with high mortality and morbidity rates. We aimed to study the protective role of silymarin and mesenchymal stem
cells as a therapeutic tool of cisplatin nephrotoxicity.
Materials and Methods: We injected rats with cisplatin in a dose of 5 mg/kg body weight for 5 days to induce acute renal
failure (ARF). Silymarin was administrated 6 hours before cisplatin injection and mesenchymal stem cells were injected 24
hours after cisplatin-induced ARF.
Results: We assessed the ARF biochemically by elevation of kidney function tests and histopathologically by an alteration
of the histological architecture of the renal cortex in the form of shrinkage of glomeruli, lobulated tufts and glomerular
hypertrophy with narrowing capsular space. The tubules showed extensive tubular degeneration with cellular hyaline
materials and debris in the lumen of the renal tubules. The renal blood vessels appeared sclerotic with marked thickened
walls. When silymarin was given in different doses before cisplatin, it decreased the toxic effect of cisplatin in the kidney but
sclerotic blood vessels remained. Injection of mesenchymal stem cells in rats with cisplatin-induced ARF improved the
histopathological effects of cisplatin in renal tissues and kidney function tests were significantly improved.
Conclusions: There was a significant improvement in kidney function tests and renal histopathology by using silymarin as
protective mechanism in cisplatin-induced ARF. Administration of mesenchymal stem cells denoted a more remarkable
therapeutic effect in ARF.
associated with high mortality and morbidity rates. We aimed to study the protective role of silymarin and mesenchymal stem
cells as a therapeutic tool of cisplatin nephrotoxicity.
Materials and Methods: We injected rats with cisplatin in a dose of 5 mg/kg body weight for 5 days to induce acute renal
failure (ARF). Silymarin was administrated 6 hours before cisplatin injection and mesenchymal stem cells were injected 24
hours after cisplatin-induced ARF.
Results: We assessed the ARF biochemically by elevation of kidney function tests and histopathologically by an alteration
of the histological architecture of the renal cortex in the form of shrinkage of glomeruli, lobulated tufts and glomerular
hypertrophy with narrowing capsular space. The tubules showed extensive tubular degeneration with cellular hyaline
materials and debris in the lumen of the renal tubules. The renal blood vessels appeared sclerotic with marked thickened
walls. When silymarin was given in different doses before cisplatin, it decreased the toxic effect of cisplatin in the kidney but
sclerotic blood vessels remained. Injection of mesenchymal stem cells in rats with cisplatin-induced ARF improved the
histopathological effects of cisplatin in renal tissues and kidney function tests were significantly improved.
Conclusions: There was a significant improvement in kidney function tests and renal histopathology by using silymarin as
protective mechanism in cisplatin-induced ARF. Administration of mesenchymal stem cells denoted a more remarkable
therapeutic effect in ARF.